Clinical trial Recruiting at 1 site Interventional Ages 9 to 18

Paced breathing to improve autonomic function after pediatric concussion

Official title: Impact of a Paced Breathing Exercise Intervention on Autonomic Nervous System Function and Symptom Severity in Youth Post-concussion: a Pilot Feasibility Study

Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT07572734 · Data updated 2026-11-12

This project tests whether a daily 10-minute paced breathing exercise started within 72 hours of injury can help children and teens (ages 9–18) recover faster and reduce autonomic-related symptoms after concussion.

Quick facts

Study typeInterventional
Ages9 Years to 18 Years
SexAll
Enrollment20 (estimated)
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre
Academic / other
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedMay 1, 2026
Main results expectedMay 30, 2027
Study endsMay 30, 2027
Registry record updatedMay 12, 2026
Trial IDNCT07572734 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents aged 9–18 who present to the emergency department within 0–72 hours after concussion and report at least one autonomic-related post-concussion symptom are ideal candidates.

Probably not a fit

Patients with known heart disease, prior neurological disorders other than concussion, those presenting more than 72 hours after injury, or those without autonomic-type symptoms are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized pilot compares a home-based, daily 10-minute paced breathing program to usual care for children and adolescents who present to the emergency department within 0–72 hours after concussion. Participants aged 9–18 perform the breathing exercise each day, record sessions in a log, and receive weekly phone check-ins to monitor recovery and adjust instructions as needed. The primary aim is to determine feasibility of administering the intervention in the acute post-injury period, with secondary measures including autonomic-related symptom severity, overall post-concussion symptoms, anxiety, sleep, and time to symptom improvement. The trial is conducted at the Montreal Children's Hospital under the McGill University Health Centre.

Why it matters

Potential benefit: If successful, this simple, low-risk breathing program could speed recovery and reduce autonomic and post-concussion symptoms in children and adolescents.

How similar studies have gone: Breathing and heart-rate variability interventions have shown benefits for anxiety and autonomic regulation in other populations, but evidence specifically for early pediatric concussion is limited to small or pilot studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 9-18 years old
* 0-72 hours post-concussion
* present to the ED with at least one post-concussion symptom in the Post-concussion Symptom Inventory (PSCI) that is relevant to ANS dysfunction (e.g. dizziness, nausea, fatigue, confusion, anxiety or sleep disturbances)

Exclusion Criteria:

* known heart disease,
* previous neurological problems other than concussion

Where it's running

  • Montreal Children's Hospital
    Montreal, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.